Form 4 for TNYA Tenaya Therapeutics, Inc.
Accepted 2025-05-16 00:00:00 ET · period of report 2025-05-16 · accession 0000950170-25-073824 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-05-16 | 2025-05-16 | TNYA | Tingley Whittemore | Chief Medical Off | S - Sale | $0.44 | -2,937 | 171.9K | -2% | -$1,292 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-05-16 | S | D | 2,937 | $0.44 | 171,856 | D | — | — | (F2) Includes 107,507 shares of Tenaya Therapeutics, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units. |